Myelosuppression Behandling med Tasigna er associeret med (National Cancer Institute Common Toxicity Criteria grad 3- 4) trombocytopeni, neutropeni og anæmi.
Myelosuppressio A Tasigna- kezelés (National Cancer Institute Common Toxicity Criteria 3- 4. fokú) thrombocytopenia, neutropenia és anaemia kialakulásával jár.